August 30, 2017
Author: Gavin Murdoch, Senior Director, Strategic Partnerships, Global Business Management, Patheon
The traditional business model for in-house pharmaceutical manufacturing is nearly a thing of the past. More companies are turning to outsourcing to achieve flexibility and efficiency in a highly competitive market.
Learn how companies that ultimately decide to outsource often underestimate the time required once the decision has been made.